Donanemab for Alzheimer Disease-Who Benefits and Who Is Harmed?

TitleDonanemab for Alzheimer Disease-Who Benefits and Who Is Harmed?
Publication TypeJournal Article
Year of Publication2023
AuthorsManly, JJ, Deters, KD
JournalJAMA
Date Published2023 Jul 17
ISSN1538-3598
DOI10.1001/jama.2023.11704
Alternate JournalJAMA
PubMed ID37459138